Bengt Falk
Chairman presso Evolva A/S
Profilo
Bengt Falk was the founder of Biotage AB (1995), where he served as Chairman until 2004.
He is also the founder of Personal Chemistry.
Currently, he holds the position of Chairman at Evolva A, Aprovix Laboratories AB, Sporthyra i Stockholm Uppsala AB, Director at PRFA Management AB, and Director at Recepton AB.
Dr. Falk's former positions include President & Chief Executive Officer at Biacore International AB (1989-1992), Chief Executive Officer at Novavax AB (2003-2009), Chief Executive Officer at Alfa Star SA (1985-1989), Chairman at Aprovix AB (2005-2014), Chairman at Wavecraft I Uppsala AB (2012-2014), Director at Sidec AB (2003-2009), Director at Nanoxis AB (2004-2014), Director at Neobiotics AB (2012-2014), Vice President-Research & Development at Pharmacia Biotech AB (1994-2002), and Vice President-Research Development at Amersham Pharmacia Biotech Corp.
(1980-1985).
Dr. Falk's education includes an undergraduate degree from the University of Oxford and a doctorate degree from the University of Lund (1977).
Posizioni attive di Bengt Falk
| Società | Posizione | Inizio |
|---|---|---|
| Evolva A/S | Chairman | - |
| Aprovix Laboratories AB | Chairman | - |
| PRFA Management AB | Director/Board Member | - |
| Recepton AB | Director/Board Member | - |
| Sporthyra i Stockholm Uppsala AB | Chairman | - |
Precedenti posizioni note di Bengt Falk
| Società | Posizione | Fine |
|---|---|---|
Aprovix AB
 Aprovix AB Medical SpecialtiesHealth Technology Aprovix AB develops, manufactures and supplies a device for early detection of pre-stages of cervix cancer. The company was founded by Erik Wilander in 2001 and is headquartered in Uppsala, Sweden. | Chairman | 01/06/2014 |
| NEOS AB | Director/Board Member | 01/06/2014 |
| Wavecraft I Uppsala AB | Chairman | 01/06/2014 |
Neobiotics AB
 Neobiotics AB Miscellaneous Commercial ServicesCommercial Services Neobiotics AB provides research services to the healthcare sector. It develops pharmaceutical products to combat multi-resistant bacteria and viruses. It explores unique substances with antiviral and antibacterial activities based upon novel molecular mechanisms, even inhibiting multi-resistant bacterial strains. The company was founded in 2005 and is headquartered in Lund, Sweden. | Corporate Officer/Principal | 01/06/2014 |
| ░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Formazione di Bengt Falk
| University of Oxford | Undergraduate Degree |
| University of Lund | Doctorate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 4 |
|---|---|
| BIOTAGE AB | Health Technology |
| PHASE HOLOGRAPHIC IMAGING PHI AB | Health Technology |
| NEOS AB | Health Technology |
| VICORE PHARMA HOLDING AB | Health Technology |
| Aziende private | 17 |
|---|---|
Biacore International AB
 Biacore International AB Pharmaceuticals: MajorHealth Technology Biacore International AB offers systems that generate data on the interactions between proteins and small molecule drug candidates. Its systems are used in pharmaceutical drug discovery, antibody characterization, proteomics, immunogenicity, biotherapeutic development and manufacture and life science research applications. The company serves research centers, pharmaceutical and biotechnology companies. Biacore International markets its products in the United States, Europe, Japan and Australia. The company was founded in 1984 and is headquartered in Uppsala, Sweden | Health Technology |
| Personal Chemistry | Health Technology |
| Pharmacia Biotech AB | Health Technology |
Novavax AB
 Novavax AB Pharmaceuticals: GenericHealth Technology Novavax AB is engaged in research and development of vaccines. Its products include Matrix and AbiSCO. The company was founded by Bror Morein in 1999 and is headquartered in Uppsala, Sweden. | Health Technology |
Sidec AB
 Sidec AB BiotechnologyHealth Technology Sidec studies molecular interactions in situ and in vitro using its proprietary technology Protein Tomography(TM). Sidec AB offers collaborative research projects to the biopharmaceutical industry that reveal unique information to prioritize the most promising therapeutic antibody and to locate the antibody binding epitope. | Health Technology |
| Amersham Pharmacia Biotech Corp. | |
Nanoxis AB
 Nanoxis AB Miscellaneous Commercial ServicesCommercial Services Nanoxis AB provides tools and services for membrane protein research. It specializes in research and development of nanofabrication technologies in soft polymer and fluid-state liquid crystalline material. The company was founded by Owe Orwar and Anders Karlsson in November 2002 and is headquartered in Gothenburg, Sweden. | Commercial Services |
Prospero Biotech Ltd.
 Prospero Biotech Ltd. Investment ManagersFinance Prospero Biotech Ltd. (Prospero) is an independent UK private equity firm which specializes in providing formation management to early-stage bioventures. Based in London, Prosepro seeks to work with academic institutions who wish to commercialize their technology base, biotech ventures that may want to access new markets or that want to spin-off or sell a technology that is no longer core to their interests or corporations aiming to develop high potential new ventures in the medical or biotech sectors. | Finance |
Neobiotics AB
Neobiotics AB Miscellaneous Commercial ServicesCommercial Services Neobiotics AB provides research services to the healthcare sector. It develops pharmaceutical products to combat multi-resistant bacteria and viruses. It explores unique substances with antiviral and antibacterial activities based upon novel molecular mechanisms, even inhibiting multi-resistant bacterial strains. The company was founded in 2005 and is headquartered in Lund, Sweden. | Commercial Services |
Alfa Star SA
 Alfa Star SA Other Consumer ServicesConsumer Services Alfa Star SA engages in the provision of tourism and hospitality services. The company offers tours and recreational activities. It engages in the planning and organizing group trips. The company was founded in 1995 and is headquartered in Warsaw, Poland. | Consumer Services |
Aprovix AB
Aprovix AB Medical SpecialtiesHealth Technology Aprovix AB develops, manufactures and supplies a device for early detection of pre-stages of cervix cancer. The company was founded by Erik Wilander in 2001 and is headquartered in Uppsala, Sweden. | Health Technology |
| Evolva A/S | |
| Aprovix Laboratories AB | |
| PRFA Management AB | |
| Recepton AB | |
| Wavecraft I Uppsala AB | Health Technology |
| Sporthyra i Stockholm Uppsala AB |
- Borsa valori
- Insiders
- Bengt Falk
